4//SEC Filing
LUNDBERG MAGNUS 4
Accession 0001179110-13-005086
CIK 0001012140other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 7:37 PM ET
Size
7.8 KB
Accession
0001179110-13-005086
Insider Transaction Report
Form 4
LUNDBERG MAGNUS
Director
Transactions
- Exercise/Conversion
Common Stock
2013-03-11$38.85/sh+5,000$194,250→ 17,116 total - Sale
Common Stock
2013-03-11$88.00/sh−5,000$440,000→ 12,116 total - Exercise/Conversion
Stock Option (Right to Buy)
2013-03-11−5,000→ 0 totalExercise: $38.85From: 2005-06-08Exp: 2014-06-08→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]Shares sold pursuant to a 10b5-1 plan.
Documents
Issuer
ONYX PHARMACEUTICALS INC
CIK 0001012140
Entity typeother
Related Parties
1- filerCIK 0001235944
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 7:37 PM ET
- Size
- 7.8 KB